Subsequently, immunohistochemical (IHC) analyses were performed on 80 breast cancer specimens alongside adjacent normal tissues, demonstrating that UBD was expressed at significantly higher levels in invasive tumor tissues as opposed to adjacent normal tissues and ductal carcinoma in situ (Fig. 1D and E). The gene discussed is UBD; the disease is ductal breast carcinoma in situ.